SCHEMBL1020719

SCHEMBL1020719

Cc1ccc(F)cc1N=C=S

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
LMNA P02545 2/20 0.46
CYP3A4 P08684 2/20 0.40
TRPA1 O75762 1/20 0.40
MIF P14174 3/20 0.34
TDP1 Q9NUW8 2/20 0.33
SLC6A4 P31645 2/20 0.33
ABCB11 O95342 1/20 0.33
NR3C1 P04150 1/20 0.33
CYP1A2 P05177 1/20 0.33
ADRA2A P08913 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
ADRA2C P18825 1/20 0.33
MAOA P21397 1/20 0.33
DRD1 P21728 1/20 0.33
HTR2B P41595 1/20 0.33
CCR2 P41597 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29401800 1.00 ALDH1A1 (0.46) ALDH1A1LMNACYP3A4TRPA1MIF
SCHEMBL893836 0.84 ALDH1A1 (0.36) ALDH1A1LMNACYP3A4MIFTDP1
SCHEMBL1022418 0.80 CYP3A4 (0.63) ALDH1A1LMNACYP3A4TRPA1TDP1
SCHEMBL30940601 0.79 CA3 (0.38) ALDH1A1LMNACYP3A4MIFTDP1
SCHEMBL191588 0.79 ALDH1A1 (0.49) ALDH1A1LMNACYP3A4TRPA1MIF
SCHEMBL30785389 0.79 ALDH1A1 (0.49) ALDH1A1LMNACYP3A4TRPA1MIF
SCHEMBL1457805 0.79 CA3 (0.38) ALDH1A1LMNACYP3A4MIFTDP1
SCHEMBL29463953 0.78 CYP3A4 (0.60) ALDH1A1LMNACYP3A4TRPA1MIF
SCHEMBL484205 0.78 CYP3A4 (0.60) ALDH1A1LMNACYP3A4TRPA1MIF
SCHEMBL30157452 0.76 ALDH1A1 (0.46) ALDH1A1LMNACYP3A4TRPA1MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3958865-B1 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES BAYER AG (DE) 2025-12-10 EP disclosed
US-12403135-B2 4H-pyrrolo[3,2-c]pyridin-4-one derivatives BAYER AKTIENGESELLSCHAFT (DE) 2025-09-02 US disclosed
EP-3700904-B1 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES BAYER AG (DE) 2023-07-19 EP disclosed
US-20220378762-A1 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2022-12-01 US disclosed
US-11339157-B1 4H-pyrrolo[3,2-c]pyridin-4-one derivatives BAYER AKTIENGESELLSCHAFT (DE) 2022-05-24 US disclosed
CN-109415602-B 2-cyanoacrylate-based adhesive composition 东亚合成株式会社 2021-05-25 CN disclosed
WO-2020216774-A1 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2020-10-29 WO disclosed
US-10793749-B2 2-cyanoacrylate-based adhesive composition TOAGOSEI CO., LTD. (JP) 2020-10-06 US disclosed
EP-3700904-A1 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES Bayer AG (DE) 2020-09-02 EP disclosed
EP-3296309-B1 GALACTOPYRANOSYL DERIVATIVES USEFUL AS MEDICAMENTS UNIV GENT (BE) 2019-08-07 EP disclosed
EP-1126833-A2 OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF TREGA BIOSCIENCES, INC. (US) 2001-08-29 EP disclosed
WO-2000025768-A1 OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF TREGA BIOSCIENCES, INC. (US) 2000-05-11 WO disclosed
US-5877324-A ANTICHOLESTEROL AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 1999-03-02 US disclosed
EP-0876354-A1 2-(SUBSTITUTED SULFANYL)-3,5-DIHYDRO-IMIDAZOL-4-ONE DERIVATIVES AMERICAN HOME PRODUCTS CORPORATION (US) 1998-11-11 EP disclosed
EP-0876355-A1 2-THIOXO-IMIDAZOLIDIN-4-ONE DERIVATIVES AND THEIR USE FOR INCREASING HDL CHOLESTEROL CONCENTRATION AMERICAN HOME PRODUCTS CORPORATION (US) 1998-11-11 EP disclosed
US-5821372-A USEFUL FOR INCREASING BLOOD SERUM HIGH DENSITY LIPOPROTEIN LEVELS(HDL) AMERICAN HOME PRODUCTS CORPORATION (US) 1998-10-13 US disclosed
WO-1997019931-A1 2-(SUBSTITUTED SULFANYL)-3,5-DIHYDRO-IMIDAZOL-4-ONE DERIVATIVES AMERICAN HOME PRODUCTS CORPORATION (US) 1997-06-05 WO disclosed
WO-1997019932-A1 2-THIOXO-IMIDAZOLIDIN-4-ONE DERIVATIVES AND THEIR USE FOR INCREASING HDL CHOLESTEROL CONCENTRATION AMERICAN HOME PRODUCTS CORPORATION (US) 1997-06-05 WO disclosed
US-5599829-A FOR INCREASED HIGH DENSITY LIPOPROTEIN LEVELS IN BLOOD AMERICAN HOME PRODUCTS CORPORATION (US) 1997-02-04 US disclosed
US-5554607-A INCREASING HDL CHOLESTEROL AMERICAN HOME PRODUCTS CORPORATION (US) 1996-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220378762-A1 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES EGFR, ERBB2, ERBB4 ALDH1A1 1255/4885LMNA 2835/4885CYP3A4 670/4885
US-12403135-B2 4H-pyrrolo[3,2-c]pyridin-4-one derivatives EGFR, ERBB2, ERBB4 ALDH1A1 1255/4885LMNA 2835/4885CYP3A4 670/4885
US-11339157-B1 4H-pyrrolo[3,2-c]pyridin-4-one derivatives CYP4B1, CYP2C19, CYP3A4 ALDH1A1 387/4885LMNA 1988/4885CYP3A4 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.